Puberty as an accelerator for diabetes complications

Ehehalt, 2010, Epidemiological perspectives on type 1 diabetes in childhood and adolescence in Germany: 20 years of the Baden-Wurttemberg Diabetes Incidence Registry (DIARY), Diabetes Care, 33, 338, 10.2337/dc09-1503

Patterson, 2009, Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study, Lancet, 373, 2027, 10.1016/S0140-6736(09)60568-7

Mortensen, 1997, Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes, Diabetes Care, 20, 714, 10.2337/diacare.20.5.714

Kostraba, 1989, Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects, Diabetes Care, 12, 686, 10.2337/diacare.12.10.686

Donaghue, 2003, Do all prepubertal years of diabetes duration contribute equally to diabetes complications?, Diabetes Care, 26, 1224, 10.2337/diacare.26.4.1224

Hietala, 2010, Age at onset and the risk of proliferative retinopathy in type 1 diabetes, Diabetes Care, 33, 1315, 10.2337/dc09-2278

Burger, 1986, Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study, Diabetologia, 29, 17, 10.1007/BF02427275

Danne, 1994, Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study, Diabetes Care, 17, 1390, 10.2337/diacare.17.12.1390

Svensson, 2004, Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden, Diabetes Care, 27, 955, 10.2337/diacare.27.4.955

Finne, 2005, Incidence of end-stage renal disease in patients with type 1 diabetes, JAMA, 294, 1782, 10.1001/jama.294.14.1782

Mollsten, 2010, Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study, Diabetes, 59, 1803, 10.2337/db09-1744

Svensson, 2006, Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study, Diabetes Care, 29, 538, 10.2337/diacare.29.03.06.dc05-1531

Krolewski, 1985, The changing natural history of nephropathy in type I diabetes, Am J Med, 78, 785, 10.1016/0002-9343(85)90284-0

Schultz, 1999, Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group, Diabetes Care, 22, 495, 10.2337/diacare.22.3.495

Holl, 1999, Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control, Diabetes Care, 22, 1555, 10.2337/diacare.22.9.1555

Donaghue, 1997, The effect of prepubertal diabetes duration on diabetes. Microvascular complications in early and late adolescence, Diabetes Care, 20, 77, 10.2337/diacare.20.1.77

Donaghue, 2005, Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes, Diabet Med, 22, 711, 10.1111/j.1464-5491.2005.01527.x

Gallego, 2008, Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study, BMJ, 337, a918, 10.1136/bmj.a918

Amin, 2003, Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study, Diabetes Care, 26, 1456, 10.2337/diacare.26.5.1456

Orchard, 1990, Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II, Diabetes, 39, 1116, 10.2337/diab.39.9.1116

Seliger, 2001, Gender and the progression of renal disease, Curr Opin Nephrol Hypertens, 10, 219, 10.1097/00041552-200103000-00010

Sibley, 2006, Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity, Am J Kidney Dis, 47, 223, 10.1053/j.ajkd.2005.10.021

Schweiger, 2010, Menarchal timing in type 1 diabetes through the last 4 decades, Diabetes Care, 33, 2521, 10.2337/dc10-0872

Laing, 2003, Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes, Diabetologia, 46, 760, 10.1007/s00125-003-1116-6

Pareyn, 2013, Impaired endothelial function in female adolescents with type 1 diabetes measured by peripheral artery tonometry, Eur J Pediatr, 172, 1017, 10.1007/s00431-013-1988-5

Sonksen, 1993, Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?, Horm Res, 40, 68, 10.1159/000183770

Alzaid, 1994, The role of growth hormone in the development of diabetic retinopathy, Diabetes Care, 17, 531, 10.2337/diacare.17.6.531

Ray, 1968, Pituitary ablation for diabetic retinopathy. I. Results of hypophysectomy. (A ten-year evaluation), JAMA, 203, 79, 10.1001/jama.1968.03140020007002

Mohamed, 2007, Management of diabetic retinopathy: a systematic review, JAMA, 298, 902, 10.1001/jama.298.8.902

Rudberg, 1998, Serum leptin levels in young females with insulin-dependent diabetes and the relationship to hyperandrogenicity and microalbuminuria, Horm Res, 50, 297, 10.1159/000023294

Conway, 2010, Temporal patterns in overweight and obesity in type 1 diabetes, Diabet Med, 27, 398, 10.1111/j.1464-5491.2010.02956.x

Stone, 2006, Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study, Diabetes Care, 29, 2072, 10.2337/dc06-0239

Ingberg, 2003, Body composition in adolescent girls with type 1 diabetes, Diabet Med, 20, 1005, 10.1046/j.1464-5491.2003.01055.x

Codner, 2004, Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type-1 diabetes mellitus, Pediatr Diabetes, 5, 182, 10.1111/j.1399-543X.2004.00059.x

Yki-Jarvinen, 1986, Natural course of insulin resistance in type I diabetes, N Engl J Med, 315, 224, 10.1056/NEJM198607243150404

Williams, 2000, Can clinical factors estimate insulin resistance in type 1 diabetes?, Diabetes, 49, 626, 10.2337/diabetes.49.4.626

Chillaron, 2009, Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes, J Clin Endocrinol Metab, 94, 3530, 10.1210/jc.2009-0960

Kilpatrick, 2007, Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial, Diabetes Care, 30, 707, 10.2337/dc06-1982

Specht, 2013, Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes, J Pediatr, 162, 297, 10.1016/j.jpeds.2012.07.036

Nadeau, 2010, Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function, J Clin Endocrinol Metab, 95, 513, 10.1210/jc.2009-1756

Downie, 2011, Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control, Diabetes Care, 34, 2368, 10.2337/dc11-0102

Cho, 2013, Heart rate variability in pubertal girls with type 1 diabetes: its relationship with glycaemic control, insulin resistance and hyperandrogenism, Clin Endocrinol (Oxf), 10.1111/cen.12238

Amiel, 1986, Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes, N Engl J Med, 315, 215, 10.1056/NEJM198607243150402

Moran, 1999, Insulin resistance during puberty: results from clamp studies in 357 children, Diabetes, 48, 2039, 10.2337/diabetes.48.10.2039

Edge, 1990, Increased overnight growth hormone concentrations in diabetic compared with normal adolescents, J Clin Endocrinol Metab, 71, 1356, 10.1210/jcem-71-5-1356

Baxter, 1980, Association between serum insulin, serum somatomedin and liver receptors for human growth hormone in streptozotocin diabetes, Horm Metab Res, 12, 377, 10.1055/s-2007-996296

Suikkari, 1988, Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein, J Clin Endocrinol Metab, 66, 266, 10.1210/jcem-66-2-266

Batch, 1991, Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes, J Clin Endocrinol Metab, 73, 964, 10.1210/jcem-73-5-964

Escobar-Morreale, 2000, High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus, J Clin Endocrinol Metab, 85, 4182

Meyer, 2000, Serum androgen levels in adolescents with type 1 diabetes: relationship to pubertal stage and metabolic control, J Endocrinol Invest, 23, 362, 10.1007/BF03343739

Codner, 2006, Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus, J Clin Endocrinol Metab, 91, 2250, 10.1210/jc.2006-0108

Codner, 2007, Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus, J Clin Endocrinol Metab, 92, 4742, 10.1210/jc.2007-1252

Sutton-Tyrrell, 2005, Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN), Circulation, 111, 1242, 10.1161/01.CIR.0000157697.54255.CE

Danielson, 2008, Sex hormone-binding globulin and testosterone in individuals with childhood diabetes, Diabetes Care, 31, 1207, 10.2337/dc07-2169

Dam, 2003, Steroids in adult men with type 1 diabetes: a tendency to hypogonadism, Diabetes Care, 26, 1812, 10.2337/diacare.26.6.1812

Holly, 1992, Sex hormone binding globulin levels in adolescent subjects with diabetes mellitus, Diabet Med, 9, 371, 10.1111/j.1464-5491.1992.tb01799.x

Sorensen, 2009, Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty, Diabetes Care, 32, 909, 10.2337/dc08-1618

Codner, 2005, Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide, J Clin Endocrinol Metab, 90, 3939, 10.1210/jc.2005-0142

Shiuchi, 2002, ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO, Hypertension, 40, 329, 10.1161/01.HYP.0000028979.98877.0C

Jarvisalo, 1999, HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease, Atherosclerosis, 147, 237, 10.1016/S0021-9150(99)00189-6

Pitocco, 2013, Oxidative stress in diabetes: implications for vascular and other complications, Int J Mol Sci, 14, 21525, 10.3390/ijms141121525

Hamilton, 2003, Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial, Diabetes Care, 26, 138, 10.2337/diacare.26.1.138

Anderson, 2013, Does metformin improve vascular heath in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial, BMC Pediatr, 13, 108, 10.1186/1471-2431-13-108

Landt, 1985, Effects of exercise training on insulin sensitivity in adolescents with type I diabetes, Diabetes Care, 8, 461, 10.2337/diacare.8.5.461

Robertson, 2009, Exercise in children and adolescents with diabetes, Pediatr Diabetes, 10, 154, 10.1111/j.1399-5448.2009.00567.x

Copeland, 2013, Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents, Pediatrics, 131, 364, 10.1542/peds.2012-3494